Gubra Resultados de beneficios anteriores
Pasado controles de criterios 0/6
Gubra's earnings have been declining at an average annual rate of -92.7%, while the Life Sciences industry saw earnings growing at 13.9% annually. Revenues have been growing at an average rate of 10% per year.
Información clave
-92.7%
Tasa de crecimiento de los beneficios
-124.4%
Tasa de crecimiento del BPA
| Crecimiento de la industria Life Sciences | 26.8% |
| Tasa de crecimiento de los ingresos | 10.0% |
| Rentabilidad financiera | -10.0% |
| Margen neto | -20.8% |
| Próxima actualización de resultados | 28 Feb 2025 |
Actualizaciones de resultados anteriores recientes
Recent updates
Desglose de ingresos y gastos
Cómo gana y gasta dinero Gubra. Basado en los últimos beneficios reportados, en base a los últimos doce meses (LTM).
Historial de beneficios e ingresos
| Fecha | Ingresos | Beneficios | Gastos G+A | Gastos de I+D |
|---|---|---|---|---|
| 30 Jun 24 | 224 | -47 | 86 | 97 |
| 31 Mar 24 | 214 | -46 | 80 | 93 |
| 31 Dec 23 | 205 | -45 | 75 | 89 |
| 30 Sep 23 | 204 | -26 | 73 | 83 |
| 30 Jun 23 | 204 | -7 | 71 | 77 |
| 31 Mar 23 | 201 | -1 | 69 | 67 |
| 31 Dec 22 | 199 | 4 | 67 | 57 |
| 31 Dec 21 | 255 | 68 | 52 | 27 |
| 31 Dec 20 | 172 | 13 | 45 | 34 |
Ingresos de calidad: PI3 is currently unprofitable.
Margen de beneficios creciente: PI3 is currently unprofitable.
Análisis del flujo de caja libre vs. Beneficios
Análisis del crecimiento de los beneficios en el pasado
Tendencia de beneficios: PI3 is unprofitable, and losses have increased over the past 5 years at a rate of 92.7% per year.
Acelerando crecimiento: Unable to compare PI3's earnings growth over the past year to its 5-year average as it is currently unprofitable
Beneficios vs. Industria: PI3 is unprofitable, making it difficult to compare its past year earnings growth to the Life Sciences industry (-0.7%).
Rentabilidad financiera
Alta ROE: PI3 has a negative Return on Equity (-10.03%), as it is currently unprofitable.